Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-02-02

Clinical Trial Update: Nursing and Pharmacy Time for Delivering Xeloda® Versus 5-Fluoruracil Regimens

View source ↗

Summary

Terminated clinical trial comparing nursing and pharmacy time for delivering capecitabine (Xeloda) versus standard 5-fluorouracil regimens in colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 5-Fluorouracil (5-FU)
  • Xeloda (capecitabine)

Snippet

Sponsor: Vivian Wing Yan Lee | Conditions: Colorectal Cancer | Status: TERMINATED